Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRO 140 IV in HIV-1 Infection
NCT00613379Phase 2Completed
- Sponsor
- CytoDyn Inc.
- Start
- Dec 2007
- Primary completion
- Aug 2008
- Modality
- Prophylactic Vaccines, Therapeutic Vaccines, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of leronlimab in human immunodeficiency virus type 1 infection (HIV-1), sponsored by CytoDyn Inc.. Started Dec 2007; status: completed.
02
Drugs
leronlimab
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00613379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00613379.